Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial

NCT03578822 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischaemic Stroke

Interventions

DRUG: Recombinant human urokinase
DRUG: Aspirin
DRUG: rhPro-UK simulation agent
DRUG: Aspirin simulation agent

Sponsor

Tasly Biopharmaceuticals Co., Ltd.